Immunohistochemical loss of succinate dehydrogenase subunit a (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation

Markku Miettinen, Jonathan Keith Killian, Zeng Feng Wang, Jerzy Lasota, Christopher Lau, Laura Jones, Robert Walker, Marbin Pineda, Yuelin Jack Zhu, Su Y. Kim, Lee Helman, Paul Meltzer

Research output: Contribution to journalArticle

Abstract

A subset (7% to 10%) of gastric gastrointestinal stromal tumors (GISTs) is notable for the immunohistochemical loss of succinate dehydrogenase (SDH) subunit B (SDHB), which signals the loss of function of the SDH complex consisting of mitochondrial inner membrane proteins. These SDH-deficient GISTs are known to be KIT/PDGFRA wild type, and most patients affected by this subset of GISTs are young. Some of these patients have germline mutations of SDH subunit genes SDHB, SDHC, or SDHD, known as Carney-Stratakis syndrome when combined with paraganglioma. More recently, germline mutations in SDH subunit A gene (SDHA) have also been reported in few patients with KIT/PDGFRA wild-type GISTs. In this study we immunohistochemically examined 127 SDHB-negative and 556 SDHB-positive gastric GISTs and 261 SDHB-positive intestinal GISTs for SDHA expression using a mouse monoclonal antibody 2E3 (Abcam). Cases with available DNA were tested for SDHA, SDHB, SDHC, and SDHD gene mutations using a hybridization-based custom capture next-generation sequencing assay. A total of 36 SDHA-negative GISTs (28%) were found among 127 SDHB-negative gastric GISTs. No SDHB-positive GIST was SDHA negative. Among 7 SDHA-negative tumors analyzed, there were 7 SDHA mutants, most germline. A second hit indicating biallelic inactivation of SDHA was present in 6 of those cases. These patients had no other SDH subunit gene mutations. Among the 25 SDHA-positive, SDHB-negative GISTs analyzed, we identified 3 SDHA mutations (1 germline), and 11 SDHB, SDHC, or SDHD mutations (mostly germline), and 11 patients with no SDH mutations. Compared with patients with SDHA-positive GISTs, those with SDHA-negative GISTs had an older median age (34 vs. 21 y), lower female to male ratio (1.8 vs. 3.1) but similar mitotic counts and median tumor sizes, with a slow course of disease in most cases, despite a slightly higher rate of liver metastases. SDHA-negative GISTs comprise approximately 30% of SDHB-negative/SDH-deficient GISTs, and SDHA loss generally correlates with SDHA mutations.

Original languageEnglish (US)
Pages (from-to)234-240
Number of pages7
JournalAmerican Journal of Surgical Pathology
Volume37
Issue number2
DOIs
StatePublished - Feb 2013

Keywords

  • GIST
  • SDHA
  • SDHB
  • immunohistochemistry
  • mutation analysis
  • paraganglioma
  • pediatric GIST
  • prognosis
  • succinate dehydrogenase

ASJC Scopus subject areas

  • Anatomy
  • Surgery
  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Immunohistochemical loss of succinate dehydrogenase subunit a (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation'. Together they form a unique fingerprint.

  • Cite this

    Miettinen, M., Killian, J. K., Wang, Z. F., Lasota, J., Lau, C., Jones, L., Walker, R., Pineda, M., Zhu, Y. J., Kim, S. Y., Helman, L., & Meltzer, P. (2013). Immunohistochemical loss of succinate dehydrogenase subunit a (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation. American Journal of Surgical Pathology, 37(2), 234-240. https://doi.org/10.1097/PAS.0b013e3182671178